Neuralink, Elon Musk’s neurotech startup, has implanted its device in a human for the first time on Sunday, the billionaire announced on X, formerly known as Twitter. Neuralink has been working on a brain implant engineered to empower patients struck by critical paralysis. The innovative implant enables its users to master external technologies solely through neural signals. Significantly, the company commenced recruiting participants for its debut in-human clinical trial last fall, having attained approval from the U.S. Food and Drug Administration in May. Named ‘Telepathy,’ Neuralink’s first product has a significant promise. It could potentially enable patients suffering from severe degenerative diseases like ALS to establish communication or even interact with social media by maneuvering cursors and typing with their minds. Musk compares this innovation to the late Stephen Hawking, who communicated faster than an expert typist or auctioneer. Enables control of your phone or computer, and through them almost any device, just by thinking.Initial users will be those who have lost the use of their limbs. Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal.— Elon Musk (@elonmusk) January 30, 2024 The ongoing clinical trial forms a turning point in Neuralink’s journey toward commercialization. Like other medical device companies, Neuralink must undergo various phases of rigorous data safety collection and examination to secure the FDA’s final nod. The company has yet to disclose the number of human patients involved in its initial trial. There are, of course, loads of concerns regarding…Musk’s Neuralink announces first implant in human brain